Nepal pilot tests early birth control Shot's impact on breastfeeding

NCT ID NCT06816901

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This pilot study in Nepal looked at whether it is possible to run a larger trial on starting the birth control shot DMPA within 48 hours after giving birth. 40 new mothers who wanted DMPA and planned to breastfeed exclusively were enrolled. The main goal was to see if researchers could recruit enough participants, while also tracking how long it took for breast milk to come in and how many women kept using DMPA.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Depo medroxyprogesterone acetate (DMPA) injection
What this could lead to
If successful, this pilot could pave the way for a larger study that clarifies whether starting DMPA soon after birth is safe for breastfeeding and infant growth.
What could go wrong
This is a very small pilot study (40 people) focused on feasibility, not on proving safety or effectiveness. Results may not apply broadly, and the larger trial may not happen.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPOT MEDROXYPROGESTERONE ACETATE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Breast Feeding lactation disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Provincial Hospital Janakpur of Dhanusha district

    Janakpur Dham, Dhanusha District, Nepal

More trials for these conditions

Other studies related to the condition(s) this trial covers.